Neogen Corporation Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
Neogen Corporation (NEOG) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $0 as of 2011-11-30, per its 10-Q filed 2011-12-30.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2011-12-30
- 2011-11-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2011-08-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2011-05-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2011-11-30 | $0.00 10-Q · filed 2011-12-30 |
| 2011-08-31 | $0.00 10-Q · filed 2011-09-30 |
| 2011-05-31 | $0.00 10-Q · filed 2011-12-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |